1. A pharmaceutical composition comprising a mixture of coarse antigen that comprises one or several epitopes of HIV proteins - Gag and / or Pol, and nonpathogenic bakteriyu.2. A pharmaceutical composition according to claim 1, wherein said coarse antigen is selected from viral particles, virus-like particles, recombinant viral particle, conjugate of viral proteins and viral belkov.3 concatemer. A pharmaceutical composition according to claim 2, wherein said recombinant viral particles or said viral particles inaktivirovany.4. A pharmaceutical composition according to claim 1, wherein said bacterium is selected from attenuated pathogenic bacteria inactivated (optionally also weakened) pathogenic and non-pathogenic lactic acid bacteria bakteriy.5. A pharmaceutical composition according to claim 4, wherein the bacterium is a bacterium of the genus Lactobacillus.6. The pharmaceutical composition of claim 1 which is a pharmaceutical composition for administration through mucous membranes, or intradermally, or intraepitelialno.7. A pharmaceutical composition according to claim 6, which is a pharmaceutical composition for oral priema.8. A pharmaceutical composition according to claim 1 for use in a method of prophylaxis and / or treatment of HIV disease in humans, which is neobhodimo.9. A pharmaceutical composition according to claim 1 for use in a method of protecting human VICH.10. A pharmaceutical composition according to claim 1 for use in a method of protecting human seroconversion induced VICH.11. The pharmaceutical composition of claim 1 which induces and preferably maintains the antigen-specific immune protection against HIV at rights.12. Pharmaceutical compositions1. Фармацевтическая композиция, включающая смесь крупнодисперсного антигена, который содержит один или несколько эпитопов из белков ВИЧ - Gag и/или Pol, и непатогенную бактерию.2. Фармацевтическая композиция по п.1, при этом указанный крупнодисперсный антиген выбран из вирусных частиц, вирусоподобных ча
